Table 1 Demographics of IS and IR groups
From: Hyperinsulinemia improves ischemic LV function in insulin resistant subjects
Parameters | Insulin Sensitive (IS) | Insulin Resistant (IR) | P |
|---|---|---|---|
Age | 64 (8) | 64.2 (8) | ns |
Male, n (%) | 11 (92) | 10 (83) | ns |
Medication, n (%) | Â | Â | Â |
β-Blocker | 11 (92) | 11 (92) | ns |
Nitrate | 9 (75) | 6 (50) | ns |
Calcium Channel Blocker | 2 (17) | 3 (25) | ns |
Statin | 12 (100) | 11 (92) | ns |
Ejection Fraction, % | 62.2 (4) | 63.3 (6) | ns |
Coronary Disease, n (%) | Â | Â | Â |
LAD stenosis | 6 (50) | 10 (83) | ns |
LCx stenosis | 4 (33) | 3 (25) | ns |
RCA stenosis | 5 (42) | 5 (42) | ns |
Single vessel CAD | 10 (83) | 8 (67) | ns |
Two vessel CAD | 1 (8) | 2 (17) | ns |
Three vessel CAD | 1 (8) | 2 (17) | ns |
Weight (Kg) | 82 (15) | 97.5 (20) | 0.04 |
BSA (m2) | 1.96 (0.2) | 2.1 (0.2) | ns |
M Value (mg/kg/min) | 5.7 (1.3) | 2.2 (0.7) | < 0.0001 |
Diabetes* n (%) | 3 (25) | 6 (50) | ns |
   Diet controlled | 3 (25) | 2 (17) | ns |
   Metformin | 0 | 3 (25) | ns |
   Metformin and sulphonyl urea | 0 | 1 (25) | ns |